Pandemic to endemic - beyond the jab

Pandemic to endemic - beyond the jab

Sep 13
CEDA’s Pandemic to endemic series gathers leading thinkers to debate how we best balance elimination and suppression strategies and transitioning Australia from pandemic to endemic.
Do you have a login? Sign in now to prefill the registration form and access member benefits.


Laureate Professor Peter Doherty AC
Professor Raina MacIntyre, Head, Biosecurity Research Program, Kirby Institute, UNSW
Melinda Cilento, Chief Executive, CEDA
Christi Kelsey, Managing Director, GSK Australia

Event Overview

To date Australia has managed the global pandemic through non-health interventions - primarily international and state border closures, quarantine and social distancing measures.  

The future interplay between vaccinations, the role of therapeutics and other pharmaceuticals and non-drug interventions must be a conscious choice as to how we choose to progress and live with COVID-19. The important choices before us and how Australia moves forward has measurable and significant implications beyond policy and government spending - how and where we live, work and play, the health of individuals and communities and when Australia might open to the world.

So - how do we get it right?

To debate how we best manage the balancing act ahead of us at a critical moment in time join CEDA’s audience and those already considering our transition from pandemic to endemic. 

Livestream start times:
SA/NT: 11.30am
WA: 10.00am

Please note all livestream events will be recorded and registered participants will receive exclusive access to the recording following the event, ahead of the general public. Substitutions for the livestream can be made at any time. Please forward details to the event coordinator.


Meet the speakers

Laureate Professor Peter Doherty AC

Peter Doherty is an Australian immunologist and pathologist who, with Rolf Zinkernagel of Switzerland, received the Nobel Prize for Physiology or Medicine in 1996 for their discovery of how the body’s immune system distinguishes virus-infected cells from normal cells. After leading a research group at the Wistar Institute, Philadelphia, and teaching at the University of Pennsylvania (1975–82), Peter headed the department of experimental pathology at the John Curtin School of Medical Research in Canberra (1982–88) and served as chairman (1988–2001) of the department of immunology at St. Jude Children’s Research Hospital in Memphis, Tennessee, where he still holds the Michael F Tamer Chair of Biomedical Research. In 2002, he joined the faculty of medicine at the University of Melbourne, and from 2014, has been at the Peter Doherty Institute for Infection and Immunity, a joint venture between the university and the Royal Melbourne Hospital.

Professor Raina MacIntyre
Head, Biosecurity Research Program, Kirby Institute, UNSW

Raina is Professor of Global Biosecurity, NHMRC Principal Research Fellow and Head of the Biosecurity Program at the Kirby Institute, UNSW. She leads a research program in control and prevention of infectious diseases, spanning vaccinology, pandemics, bioterrorism and emerging infections, and personal protective equipment. She has led a large body of clinical trial, modelling and experimental research on face masks and respirators for prevention of respiratory transmissible infections. She is interested in surveillance for epidemics and biothreats, and developed an automated, open source rapid epidemic observatory, Epiwatch, to detect early signals of serious epidemic or bioterrorism events.

Melinda Cilento
Chief Executive, CEDA

Melinda is a company director, economist and experienced senior executive. She is a Non-Executive Director of Australian Unity and Co-Chair of Reconciliation Australia. Melinda is also a member of the Parliamentary Budget Office panel of expert advisors. Melinda was previously a Non-Executive Director with Woodside Petroleum, Commissioner with the Productivity Commission and Deputy CEO and Chief Economist with the Business Council of Australia. Melinda has also previously held senior roles with the Federal Department of Treasury, Invesco and the International Monetary Fund.

Christi Kelsey
Managing Director, GSK Australia

Christi brings over twenty years of broad industry experience with key roles across the research & development and commercial spectrum. This comes from multiple therapy areas including oncology, neurology, vaccines and respiratory in both biotech and pharmaceutical organisations across the US, Europe and Asia Pacific. Much of Christi's focus in 2020 and 2021 has been on COVID-19. GSK's response to COVID-19 has been one of the broadest in the industry, spanning development of treatments and vaccines with partners around the globe.

Supported by CEDA member

Livestream sponsor

Further sponsorship available:

Align your brand with CEDA and communicate with hard-to-reach business, government and policy leaders by sponsoring this event. Contact CEDA Programming Team on 03 9662 3544 or email
Public event advice – Coronavirus

At CEDA we are proud to regularly convene and engage speakers and audiences as an essential element of our efforts to broaden discussion and debate of the most important policy issues facing Australia. In doing so, our first priority is always the safety and wellbeing of our guests and staff.

CEDA is currently delivering a digital program of public events, podcasts and virtual Trustee roundtable discussions; hybrid events with both a livestream and audience in attendance; and face-face events, where there is member demand and they can be delivered in accordance with government health advice for a specific state.

For face-to-face gatherings, CEDA is working closely with our hosts and venues to ensure that social distancing can be maintained and facilities and equipment have been properly sanitised. Attendance numbers will strictly adhere to government guidelines for each state.In line with government advice we request people that are unwell with cough or fever or other respiratory symptoms do not attend CEDA events. We also ask that you follow government advice and maintain social distancing by refraining from shaking hands or exchanging physical greetings, and wherever possible, staying at least 1.5 metres away from others.

CEDA will continue to closely monitor government advice regarding public gatherings and will follow all relevant health advice from the Australian government in relation to COVID-19.

We acknowledge the Traditional Owners of country throughout Australia and recognise their continuing connection to land, waters and culture. We pay our respects to their Elders past, present and emerging.

Twitter feed

ABN 49 008 600 922 | © 2020 CEDA |  Privacy and data collection